Alnylam Pharmaceuticals
ALNY
#1120
Rank
$21.17 B
Marketcap
$158.12
Share price
4.27%
Change (1 day)
-64.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company